Related Experiment Video
Updated: Aug 13, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci
B E Domaracki1, A Evans, K E Preston
1Department of Pathology and Laboratory Medicine, Albany Medical Center, New York 12208, USA.
Abstract:
Vancomycin resistance in methicillin-resistant staphylococci presents a potential therapeutic problem. In order to understand the impact of low-level vancomycin resistance in coagulase-negative staphylococci, stepwise selection of vancomycin resistance was accomplished by growing Staphylococcus haemolyticus in culture media with increasing concentrations of vancomycin. A >40-fold increase in susceptibility to beta-lactam antibiotics was observed. No obvious alterations in the growth curve, the presence of the mecA gene, total DNA restriction fragment length polymorphism (RFLP), beta-lactamase production, or the crude protein fraction were detected in the Staphylococcus haemolyticus-derived clones when compared to the original isolate. The proportion of the oxacillin-heteroresistant population also remained similar. A comparable phenomenon occurred with the selection of Staphylococcus epidermidis exhibiting low-level resistance to vancomycin. Additionally, it was observed that clinical isolates of coagulase-negative staphylococci grown in the presence of sub-minimum inhibitory concentrations of either vancomycin or teicoplanin lost their high-level resistance to oxacillin. Checkerboard tests showed that the combination of vancomycin and oxacillin was synergistic for two isolates of Staphylococcus haemolyticus, two of four isolates of Staphylococcus epidermidis, and one isolate of Staphylococcus hominis.
Insights
Developing vancomycin resistance in staphylococci unexpectedly increased susceptibility to beta-lactam antibiotics. This finding challenges current understanding and suggests new therapeutic strategies for resistant bacterial infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Antibiotic Resistance
Background:
- Methicillin-resistant staphylococci (MRS) pose significant therapeutic challenges due to antibiotic resistance.
- Vancomycin resistance in staphylococci is a growing concern, potentially limiting treatment options.
Purpose of the Study:
- To investigate the impact of low-level vancomycin resistance on coagulase-negative staphylococci (CoNS).
- To explore the relationship between vancomycin resistance and susceptibility to other antibiotics, particularly beta-lactams.
Main Methods:
- Stepwise selection of vancomycin resistance in Staphylococcus haemolyticus and Staphylococcus epidermidis using increasing vancomycin concentrations.
- Analysis of genetic and phenotypic markers including mecA gene presence, RFLP, beta-lactamase production, and protein fractions.
- Evaluation of oxacillin susceptibility and checkerboard assays to assess synergistic effects of vancomycin and oxacillin combinations.
Main Results:
- Selected vancomycin-resistant Staphylococcus haemolyticus clones showed a >40-fold increase in susceptibility to beta-lactam antibiotics.
- No significant changes were observed in growth curves, mecA gene, RFLP, beta-lactamase production, or protein profiles.
- Clinical isolates of CoNS exposed to sub-inhibitory concentrations of vancomycin or teicoplanin lost high-level oxacillin resistance.
- Synergistic activity between vancomycin and oxacillin was observed in several CoNS isolates.
Conclusions:
- Inducing low-level vancomycin resistance in CoNS can paradoxically enhance susceptibility to beta-lactam antibiotics.
- This phenomenon suggests complex adaptive mechanisms in staphylococci and potential for novel therapeutic approaches.
- Combination therapy with vancomycin and oxacillin may be effective against certain resistant staphylococcal strains.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance

